We were very hopeful that we would verify there was an anti-cancer effect. We ended up showing no change in cancer or cancer death.
If there was anything there, we would have seen it in these clinical trials.
It really is a great drug for heart disease.
With these stronger studies suggesting no benefit, that's pretty much the end of the road. People need to really focus in on using something else.
In our study we did a meta-analysis of all the trials, and were not able to show any reduction in cancer or in cancer deaths.